References:
1. Adeyinka A, Bailey K, Pierre L, Kondamudi N. COVID 19 infection: Pediatric perspectives. Journal of the American College of Emergency Physicians Open. 2021;2(1):e12375.
2. Guarner J. Three Emerging Coronaviruses in Two Decades: The Story of SARS, MERS, and Now COVID-19. American Journal of Clinical Pathology. 2020;153(4):420-1.
3. Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18(8):e217-e27.
4. Nashwan AJ, Villar RC, Al-Qudimat AR, Kader N, Alabdulla M, Abujaber AA, et al. Quality of Life, Sleep Quality, Depression, Anxiety, Stress, Eating Habits, and Social Bounds in Nurses during the Coronavirus Disease 2019 Pandemic in Qatar (The PROTECTOR Study): A Cross-Sectional, Comparative Study. J Pers Med. 2021;11(9).
5. Jaiswal V, Sarfraz Z, Sarfraz A, Mukherjee D, Batra N, Hitawala G, et al. COVID-19 Infection and Myocarditis: A State-of-the-Art Systematic Review. J Prim Care Community Health. 2021;12:21501327211056800.
6. Alwani M, Yassin A, Al-Zoubi RM, Aboumarzouk OM, Nettleship J, Kelly D, et al. Sex-based differences in severity and mortality in COVID-19. Rev Med Virol. 2021;31(6):e2223.
7. CDC. COVID-19 Cases, Deaths, and Trends in the US | CDC COVID Data Tracker. Centers for Disease Control and Prevention. Published March 28, 2020. Accessed December 11, 2020. https://covid.cdc.gov/ covid-data-tracker.
8. CDCMMWR. Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69. 10. 15585/mmwr.mm6914e4
9. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatrics. 2020;174(9):868-73.
10. Zhang SF, Tuo JL, Huang XB, Zhu X, Zhang DM, Zhou K, et al. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One. 2018;13(1):e0191789.
11. Tang P, Hasan MR, Chemaitelly H, Yassine HM, Benslimane FM, Al Khatib HA, et al. BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar. Nat Med. 2021.
12. Iheanacho CO, Eze UIH, Adida EA. A systematic review of effectiveness of BNT162b2 mRNA and ChAdOx1 adenoviral vector COVID-19 vaccines in the general population. Bull Natl Res Cent. 2021;45(1):150.
13. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 Among Children in China. Pediatrics. 2020;145(6).
14. Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. N Engl J Med. 2020;382(17):1663-5.
15. Parums DV. Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy. Med Sci Monit. 2021;27:e934625.
16. Wherry EJ, Jaffee EM, Warren N, D’Souza G, Ribas A. How Did We Get a COVID-19 Vaccine in Less Than 1 Year? Clin Cancer Res. 2021;27(8):2136-8.
17. Ros-DeMarize R, Chung P, Stewart R. 2021. Pediatric behavioral telehealth in the age of COVID-19: Brief evidence review and practice considerations. Current Problems in Pediatric and Adolescent Health Care 51: 100949.
18. Lee MA. 2021. COVID pandemic as an incubator for a renewed vision of pediatric value-based healthcare.Current Problems in Pediatric and Adolescent Health Care 51: 101064
19. Chokshi B, Pletcher BA, Strait JS. 2021. A trauma-informed approach to the pediatric COVID-19 response.Current Problems in Pediatric and Adolescent Health Care 51: 100970
20. Verma S, Lumba R, Lighter JL, Bailey SM, Wachtel EV, Kunjumon B, Alessi S, Mally PV. 2020. Neonatal intensive care unit preparedness for the Novel Coronavirus Disease-2019 pandemic: A New York City hospital perspective. Current Problems in Pediatric and Adolescent Health Care 50: 100795
21. Parums DV. Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy. Med Sci Monit. 2021;27:e934625-e.
22. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLOS Medicine. 2009;6(7):e1000097.
23. Marshall M, Ferguson ID, Lewis P, Jaggi P, Gagliardo C, Collins JS, et al. Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination. Pediatrics. 2021;148(3).
24. Moeller KE, Meeks M, Reynoldson J, Douglass M. Implementation and Outcomes of COVID-19 Vaccinations at a Child and Adolescent Psychiatric Hospital. J Am Acad Child Adolesc Psychiatry. 2021:S0890-8567(21)01362-9.
25. Tano E, San Martin S, Girgis S, Martinez-Fernandez Y, Sanchez Vegas C. Perimyocarditis in Adolescents After Pfizer-BioNTech COVID-19 Vaccine. Journal of the Pediatric Infectious Diseases Society. 2021.
26. Schauer J, Buddhe S, Colyer J, Sagiv E, Law Y, Chikkabyrappa SM, et al. Myopericarditis after the Pfizer mRNA COVID-19 Vaccine in Adolescents. J Pediatr. 2021:S0022-3476(21)00665-X.
27. Dionne A, Sperotto F, Chamberlain S, Baker AL, Powell AJ, Prakash A, et al. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021.
28. Hanna C, Herrera Hernandez LP, Bu L, Kizilbash S, Najera L, Rheault MN, et al. IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine. Kidney Int. 2021;100(3):705-6.
29. CDCMMWR. Long-Term Symptoms Among Adults Tested for SARS-CoV-2 -United States, January 2020–April 2021. MMWR / September 10, 2021 / Vol. 70 / No. 36.
30. Mahase E. Covid-19: Pfizer reports 100% vaccine efficacy in children aged 12 to 15. BMJ. 2021;373:n881.
31. Goldstein E, Lipsitch M, Cevik M. On the Effect of Age on the Transmission of SARS-CoV-2 in Households, Schools, and the Community. J Infect Dis. 2021;223(3):362-9.
32. Ji LN, Chao S, Wang YJ, Li XJ, Mu XD, Lin MG, et al. Clinical features of pediatric patients with COVID-19: a report of two family cluster cases. World J Pediatr. 2020;16(3):267-70.
33. Wei M, Yuan J, Liu Y, Fu T, Yu X, Zhang Z-J. Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China. JAMA. 2020;323(13):1313-4.
34. Han Y, Zeng H, Jiang H, Yang Y, Yuan Z, Cheng X, et al. CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic. Circulation. 2020;141(20):e810-e6.
35. Li X, Guan B, Su T, Liu W, Chen M, Bin Waleed K, et al. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis. Heart. 2020;106(15):1142-7.
36. Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8.
37. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-10.
38. Xie X, Xue Q, Zhou Y, Zhu K, Liu Q, Zhang J, et al. Mental Health Status Among Children in Home Confinement During the Coronavirus Disease 2019 Outbreak in Hubei Province, China. JAMA Pediatrics. 2020;174(9):898-900.
39. Zhou SJ, Zhang LG, Wang LL, Guo ZC, Wang JQ, Chen JC, et al. Prevalence and socio-demographic correlates of psychological health problems in Chinese adolescents during the outbreak of COVID-19. Eur Child Adolesc Psychiatry. 2020;29(6):749-58.
40. Liu X, Luo WT, Li Y, Li CN, Hong ZS, Chen HL, et al. Psychological status and behavior changes of the public during the COVID-19 epidemic in China. Infect Dis Poverty. 2020;9(1):58.